RVMD – revolution medicines, inc. (US:NASDAQ)
Stock Stats
News
Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight [Yahoo! Finance]
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at HC Wainwright from $62.00 to $64.00. They now have a "buy" rating on the stock.
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Needham & Company LLC from $61.00 to $68.00. They now have a "buy" rating on the stock.
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at JPMorgan Chase & Co. from $54.00 to $63.00. They now have an "overweight" rating on the stock.
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Piper Sandler from $57.00 to $70.00. They now have an "overweight" rating on the stock.
Form 4 Revolution Medicines, For: Nov 06 Filed by: Cislini Jeff
Form SC 13G/A Revolution Medicines, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 144 Revolution Medicines, Filed by: Cislini Jeff
Form 10-Q Revolution Medicines, For: Sep 30
Form 8-K Revolution Medicines, For: Nov 06
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.